Welcome to our dedicated page for Lam Research SEC filings (Ticker: LRCX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Lam Research Corporation (NASDAQ: LRCX) SEC filings page provides access to the company’s official regulatory disclosures, offering detailed insight into its operations as a global supplier of wafer fabrication equipment and services to the semiconductor industry. These documents are a primary source for understanding Lam’s financial performance, governance, capital structure, and key corporate decisions.
Investors can review current reports on Form 8-K, where Lam reports material events such as quarterly financial results, changes in its independent registered public accounting firm, and outcomes of stockholder meetings. For example, Lam has used Form 8-K to furnish earnings releases for quarters ended June 29, 2025 and September 28, 2025, to disclose the transition of its independent auditor from Ernst & Young LLP to KPMG LLP, and to report stockholder approval of the Lam 2025 Stock Incentive Plan and amendments to its Restated Certificate of Incorporation.
The company’s definitive proxy statement on Schedule 14A provides extensive information on corporate governance, board composition, executive compensation, equity incentive plans, and the items submitted to stockholders for vote at the annual meeting. This includes proposals related to director elections, advisory votes on executive compensation, auditor ratification, amendments to the certificate of incorporation, and stockholder proposals.
Through Lam’s annual and quarterly reports filed on Forms 10-K and 10-Q, users can examine comprehensive financial statements, management’s discussion and analysis, risk factors, and segment and geographic revenue details relevant to the semiconductor machinery manufacturing business. These filings complement the summarized data in earnings releases and help explain trends in systems revenue, customer support-related revenue, margins, cash balances, and other key metrics.
On Stock Titan, Lam Research filings are updated as they are posted to the SEC’s EDGAR system. AI-powered tools can assist by highlighting important sections, summarizing complex disclosures, and helping users locate information on topics such as stock incentive plans, auditor changes, dividend declarations, and board-authorized corporate actions. This makes it easier to interpret lengthy documents like 10-Ks, 10-Qs, and proxy statements, and to track how Lam’s regulatory reporting reflects its role in the semiconductor equipment industry.
Lam Research Corporation director Eric Brandt reported selling common stock in two transactions. On February 6, 2026, he sold 17,000 shares at $220.95 per share and 18,000 shares at $230 per share.
After these sales, Brandt beneficially owned 253,705 shares of Lam Research common stock directly. This reported amount includes shares that are subject to unvested restricted stock units.
Research Corp director Anirudh Devgan reported receiving 1,141 shares of common stock on February 6, 2026 in a transaction coded “A” at a price of $0 per share, indicating an equity award. The reported amount includes shares subject to unvested restricted stock units.
Following this grant, Devgan beneficially owns 1,141 shares directly and 312 shares indirectly through a trust, reflecting his combined direct and indirect holdings in the company’s common stock.
LAM RESEARCH CORP director Anirudh Devgan amended his initial ownership report, showing two common stock positions as of February 3, 2026. One line reflects 0 shares held directly, while another reflects 312 shares held indirectly through a trust. The entry characterizes these as holdings and does not identify them as explicit purchases or sales.
Form 144 discloses a planned sale of 35,000 shares of common stock through Fidelity Brokerage Services LLC on the NASDAQ exchange. The filing lists an aggregate market value of $7,896,150.00 and an approximate sale date of February 6, 2026.
The seller’s position was acquired via restricted stock vesting from the issuer as compensation, including 32,000 shares on January 27, 2012 and 3,000 shares on January 25, 2013. Shares outstanding were 1,248,771,000 at the time referenced.
Lam Research Chief Financial Officer and EVP Douglas R. Bettinger reported the vesting of equity awards tied to the company’s stock performance. On 02/03/2026, 76,920 shares of common stock were acquired at a price of $0 through a transaction coded “M,” reflecting the settlement of equity-based compensation.
The transaction relates to 51,280 market-based performance restricted stock units granted on 03/01/2023, which vest between 0% and 150% based on Lam Research’s total shareholder return versus a semiconductor index over the 02/01/2023–01/31/2026 performance period. Following this vesting event, Bettinger directly holds 1,064,157 shares of Lam Research common stock, a figure that includes shares subject to unvested restricted stock units.
Lam Research Corporation executive Christina Correia, CVP and Chief Accounting Officer, reported settlement of equity awards tied to company performance. On 02/03/2026, 6,030 market-based performance restricted stock units were exercised, resulting in 9,045 shares of common stock at a price of $0 per share. Following this transaction, she directly beneficially owned 60,637 shares of common stock, and this amount includes shares underlying unvested restricted stock units. The original 6,030-unit performance award was granted on 03/01/2023 and is scheduled to vest between 0% and 150% on 03/01/2026 based on Lam Research total shareholder return relative to the PHLX Semiconductor Total Return Index over the period from 02/01/2023 through 01/31/2026.
Lam Research senior vice president Neil J. Fernandes reported an equity award vesting that increased his direct shareholdings. On February 3, 2026, 14,380 market-based performance restricted stock units, originally granted on March 1, 2023, were settled, resulting in the acquisition of 21,570 shares of common stock at $0 per share under transaction code M. After this transaction, he held 92,768 Lam Research common shares directly and 1,015.399 shares indirectly through a 401(k). The award’s vesting level is tied to Lam Research total shareholder return versus the PHLX Semiconductor total return index over the period from February 1, 2023 through January 31, 2026.
Lam Research executive Patrick J. Lord reported the vesting of a performance-based equity award. On 02/03/2026, he acquired 63,345 shares of Lam Research common stock at a price of
Following this transaction, Lord directly beneficially owned 138,803 common shares, an amount that includes shares subject to unvested restricted stock units. The 2023 award’s payout is tied to Lam Research’s total shareholder return versus the PHLX Semiconductor total return index over a performance period from 02/01/2023 through 01/31/2026.
Lam Research senior vice president Vahedi Vahid reported an equity award transaction involving both derivative and common shares. On 02/03/2026, 33,180 market-based performance restricted stock units with a $0 exercise price were converted, and 49,770 shares of common stock were acquired at $0, bringing his directly held stake to 300,817 shares, including shares subject to unvested restricted stock units.
The performance units were originally granted on 03/01/2023 and are designed to vest between 0% and 150% on 03/01/2026. Their vesting depends on Lam Research’s total shareholder return, including dividends, compared with the PHLX Semiconductor sector total return index over the performance period from 02/01/2023 through 01/31/2026.
Lam Research senior vice president Varadarajan Seshasayee acquired 53,925 shares of common stock on 02/03/2026 through the exercise of market-based performance restricted stock units at $0 per share. Following the transaction, he directly beneficially owned 249,564 common shares, including shares subject to unvested restricted stock units, and indirectly held 2,366.932 shares through a 401(k) plan.
The exercised award originally covered 35,950 market-based performance restricted stock units granted on 03/01/2023, with vesting tied to Lam Research total shareholder return versus the PHLX Semiconductor sector index over a performance period from 02/01/2023 through 01/31/2026.